The DOI matches its Crossref record.
Advancing an HIV vaccine; advancing vaccinology
Open accessAbstract
Of any pathogen, HIV provides perhaps the greatest challenge to successful vaccine development. Nevertheless, progress continued to be made in 2018; new vaccine concepts entered the clinic and new insights were obtained in basic research that will ultimately help to guide rational vaccine design against many ‘difficult’ pathogens. The generation of an HIV vaccine remains the holy grail for eliminating HIV infection worldwide. Major advances in 2018 centred on sequential multi-immunogen strategies that are designed to induce broadly neutralizing antibodies, identifying new targets and defining new approaches to immunogen evaluation. The fusion peptide of HIV Envelope (Env) has emerged as a potential vaccine target. Naive B cell precursor frequencies and antigen affinities are crucial in considering the likelihood of success with a germline-targeting immunogen. Off-target responses to immunogens can be reduced by glycan masking of irrelevant epitopes. Neutralization, but not other immune parameters, correlates with HIV trimer vaccine-induced protection against viral challenge in a monkey model. Electron microscopy is a rapid method to determine the specificities present in a polyclonal antibody response following vaccination or infection. The fusion peptide of HIV Envelope (Env) has emerged as a potential vaccine target. Naive B cell precursor frequencies and antigen affinities are crucial in considering the likelihood of success with a germline-targeting immunogen. Off-target responses to immunogens can be reduced by glycan masking of irrelevant epitopes. Neutralization, but not other immune parameters, correlates with HIV trimer vaccine-induced protection against viral challenge in a monkey model. Electron microscopy is a rapid method to determine the specificities present in a polyclonal antibody response following vaccination or infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
CRISPR/Cas9 therapeutics: progress and prospects
Li, T., Yang, Y., Qi, H., Cui, W., Zhang, L., Fu, X., He, X., Liu, M., Li, P.-F., & Yu, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01309-7 · Cited by 719
Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients
Bost, P., Giladi, A., Liu, Y., Bendjelal, Y., Xu, G., David, E., Blecher-Gonen, R., Cohen, M., Medaglia, C., Li, H., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.006 · Cited by 471
Tailoring Materials for Modulation of Macrophage Fate
Li, J., Jiang, X., Li, H., Gelinsky, M., & Gu, Z. (2021) · Advanced Materials · doi:10.1002/adma.202004172 · Cited by 403
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Haynes, B. F., Wiehe, K., Borrow, P., Saunders, K. O., Korber, B., Wagh, K., McMichael, A. J., Kelsoe, G., Hahn, B. H., Alt, F., et al. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00753-w · Cited by 352
Metadata
- Authors
- Burton, D. R.
- Venue
- Nature Reviews Immunology
- Published
- 2018-12-18
- Volume
- 19
- Issue
- 2
- Pages
- 77-78
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2905349504
- Cited by
- 167
- References
- 0
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advancing an HIV vaccine; advancing vaccinology. https://app.cochat.ai/papers/10.1038/s41577-018-0103-6
- The paper
- Burton, D. R. (2019). Advancing an HIV vaccine; advancing vaccinology. Nature Reviews Immunology. https://doi.org/10.1038/s41577-018-0103-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.